Immunologic Responses to a Live Attenuated Oral Cholera Vaccine
Latest Information Update: 25 Jul 2024
At a glance
- Drugs PXVX 0200 (Primary)
- Indications Cholera
- Focus Pharmacodynamics
- 22 Jul 2024 Planned End Date changed from 30 Jun 2025 to 1 Jan 2026.
- 22 Jul 2024 Planned primary completion date changed from 30 Jun 2024 to 1 Jan 2025.
- 01 Jun 2023 Status changed from suspended to recruiting.